ACADIA Pharmaceuticals
ACAD
#3830
Rank
S$3.17 B
Marketcap
$18.61
Share price
-1.25%
Change (1 day)
-19.55%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): S$0.34 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are S$0.95 Billion. , an increase over its 2023 earnings that were of -S$66.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 S$0.33 B-605.67%
2023 -S$66.88 Million-76.09%
2022 -S$0.28 Billion27.41%
2021 -S$0.22 Billion-40.38%
2020 -S$0.37 Billion19.88%
2019 -S$0.31 Billion-3.92%
2018 -S$0.32 Billion-15.04%
2017 -S$0.38 Billion6.33%
2016 -S$0.36 Billion64.55%
2015 -S$0.22 Billion77.47%
2014 -S$0.13 Billion143.69%
2013 -S$49.73 Million81.93%
2012 -S$27.34 Million-8.73%
2011 -S$29.95 Million-251.39%
2010 S$19.78 M-133.2%
2009 -S$59.59 Million-30.82%
2008 -S$86.13 Million6.43%
2007 -S$80.93 Million25.89%
2006 -S$64.28 Million36.99%
2005 -S$46.93 Million37.22%
2004 -S$34.2 Million19.96%
2003 -S$28.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$53.28 Million-115.76%๐Ÿ‡บ๐Ÿ‡ธ USA
S$14.56 B 4,206.11%๐Ÿ‡บ๐Ÿ‡ธ USA
S$16.61 B 4,813.46%๐Ÿ‡บ๐Ÿ‡ธ USA
S$22.85 B 6,658.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$10.98 Billion-3,346.73%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$50.62 Million-114.97%๐Ÿ‡บ๐Ÿ‡ธ USA